# Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

> **NCT06465810** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 1850 (estimated)

## Conditions studied

- Transthyretin Amyloidosis
- ATTR-CM
- ATTRv-PN
- ATTR
- ATTR-Mixed
- hATTR

## Interventions

- **DRUG:** Treatment of transthyretin (ATTR) amyloidosis in observational study setting

## Key facts

- **NCT ID:** NCT06465810
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2031-12-29
- **Final completion:** 2031-12-29
- **Target enrollment:** 1850 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06465810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06465810, "Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06465810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*